Accretion Nutraveda Ltd IPO: The Indian SME market continues to buzz with new opportunities, and the latest to join the fray is Accretion Nutraveda Ltd. This Ahmedabad-based healthcare CDMO (Contract Development and Manufacturing Organization) specializes in Ayurvedic and nutraceutical products. If you are looking to invest, here is everything you need to know about the Accretion Nutraveda IPO.
Accretion Nutraveda Ltd IPO Overview
Accretion Nutraveda is a growing player in the wellness sector, offering over 72 formulations including tablets, capsules, and oils. The company is hitting the market with a fresh issue to fund its automation and expansion plans.
| Key Detail | Information |
| IPO Date | January 28, 2026, to January 30, 2026 |
| Price Band | ₹122 to ₹129 per equity share |
| Lot Size | 2,000 Shares (Retail) |
| Issue Size | ₹24.77 Crore |
| Listing At | BSE SME |
| Face Value | ₹10 per share |
Accretion Nutraveda IPO GMP Today
The Grey Market Premium (GMP) is a critical indicator of market sentiment before the official listing.
- Current GMP: ₹0 (Neutral)
- Estimated Listing Price: ₹129
- Expected Gain/Loss: 0.00%
Note: GMP is volatile and purely based on unofficial market demand. High subscription numbers on the final day often lead to a jump in GMP.
Important Dates & Timeline
Investors should mark these dates on their calendars to ensure they don’t miss the bidding or allotment window.
- IPO Open Date: Wednesday, January 28, 2026
- IPO Close Date: Friday, January 30, 2026
- Allotment Finalization: Monday, February 2, 2026
- Refund Initiation: Tuesday, February 3, 2026
- Credit of Shares to Demat: Tuesday, February 3, 2026
- Listing Date: Wednesday, February 4, 2026
Lot Size and Investment Limit
As this is an SME IPO, the minimum investment is higher than mainboard IPOs. Retail investors must apply for at least one lot.
| Application Category | Lots | Shares | Amount (at Upper Band) |
| Retail (Min) | 1 | 2,000 | ₹2,58,000 |
| S-HNI (Min) | 3 | 3,000 | ₹3,87,000 |
| B-HNI (Min) | 8 | 8,000 | ₹10,32,000 |
Financial Performance (Snapshot)
The company has shown significant growth in recent years. In FY25, revenue jumped to ₹16.06 crore compared to ₹5.20 crore in FY24, representing a 208% increase.
- Profit After Tax (PAT): ₹2.61 Crore (FY25)
- Return on Equity (ROE): 68.54%
- Debt-to-Equity: 0.72 (Improving)
How to Check Accretion Nutraveda IPO Allotment Status
Once the allotment is finalized on February 2, investors can check their status through the official registrar, Kfin Technologies Ltd.
- Visit the Kfintech Allotment Portal.
- Select Accretion Nutraveda Ltd from the dropdown menu.
- Enter your PAN Number, Application Number, or DP Client ID.
- Click Submit to view your allotment status.
Should You Apply? (Review)
Strengths:
- Diversified portfolio in the booming Ayurvedic/Nutraceutical space.
- Strong export presence in the USA, Singapore, and Sri Lanka.
- Experienced management with over 16 years of expertise.
Risks:
- Short operating history (founded in 2021).
- High geographic concentration in Gujarat.
- Recent negative cash flows from operations.
Note: 📢 IPO investments are risky. All data (dates, prices, GMP) are for info only. No profit is guaranteed. Do your own research (DYOR) or talk to a pro before applying! 💸
Leave a Reply